Company: SYRA
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009279
Chunk: 67

Company: Syra Health Corp
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 2
Chunk 67
---
You should read the following discussion and analysis
of our financial condition and results of operations together with our unaudited interim condensed financial statements and the related
notes appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, this discussion and analysis contains
forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those discussed
below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed
in the section titled “Risk Factors” included in this Quarterly Report on Form 10-Q, as may be amended, supplemented or superseded
from time to time by other reports we file with the SEC. All amounts in this report are in U.S. dollars, unless otherwise noted.

Throughout this Quarterly
Report on Form 10-Q, references to “we,” “our,” “us,” the “Company,” or “Syra,”
refer to Syra Health Corp.

Overview

We are a healthcare services company promoting preventative
health, holistic wellness, health education, and equitable healthcare for all patient demographics. We leverage deep scientific and healthcare
expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome
linked to developing a healthier population. We are developing comprehensive end-to-end solutions in population health, behavioral and
mental health, and healthcare workforce. During the current quarter, we reclassified our digital health and health education revenues
into our population health division.

On October 18, 2024, we received a Notice from Nasdaq Stock Market LLC (“Nasdaq”) indicating that the bid price for its Class A common stock,
for the last 30 consecutive business days for the last thirty consecutive business days, had closed below the minimum $1.00 per share
and, as a result, the Company was not in compliance with the $1.00 minimum bid price requirement (the “Minimum Bid Price Requirement”)
for the continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2).

On April 11, 2025, we voluntarily delisted
our Class A common stock from the Nasdaq Capital Market.

Results of Operations for the Three Months Ended
March 31, 2025 and 2024

The following table summarizes selected items from
the statements of operations for the three months ended March 31, 2025 and 2024.

    For the Three Months